There is evidence that switching statins has consequences

摘要

In a previous letter (PJ,23/30 December 2006,p767),I stated that Brian Curwain was only interested in saving millions of pounds for the taxpayer,patients' quality of life being secondary.This referred to him not only advocating the changeover of patients from atorvastatin to simvastatin,but also asking community pharmacists to support him in his quest.I also posed the question as to whether or not there was sufficient evidence to show that the lifespan of patients undertaking such a change in medication would not be decreased or affected in any way.